SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,590,489 | +37.2% | 54,368 | +29.6% | 0.02% | 0.0% |
| Q2 2023 | $4,802,511 | -38.5% | 41,936 | -25.9% | 0.02% | -85.5% |
| Q1 2023 | $7,805,175 | -6.6% | 56,629 | -12.2% | 0.12% | -23.0% |
| Q4 2022 | $8,353,893 | +190.7% | 64,469 | +148.0% | 0.15% | +176.4% |
| Q3 2022 | $2,874,000 | -31.1% | 26,000 | -51.3% | 0.06% | -50.5% |
| Q1 2022 | $4,169,000 | +111.6% | 53,361 | +144.0% | 0.11% | +82.0% |
| Q4 2021 | $1,970,000 | +401.3% | 21,873 | +415.0% | 0.06% | +454.5% |
| Q3 2021 | $393,000 | -53.3% | 4,247 | -62.4% | 0.01% | -77.6% |
| Q1 2021 | $841,000 | -77.1% | 11,282 | -60.4% | 0.05% | -79.4% |
| Q4 2019 | $3,678,000 | +232.2% | 28,500 | +93.9% | 0.24% | +260.6% |
| Q3 2019 | $1,107,000 | -34.4% | 14,700 | +32.3% | 0.07% | -64.3% |
| Q2 2019 | $1,688,000 | – | 11,111 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |